기준가
$160.52
운용 규모
$8.4B
보수율
-
배당수익률
0.36%
베타
1.12
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +31.60% | +24.71% | +24.58% | +88.24% | +24.86% | +3.41% |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics Inc Ordinary Shares | 1.79% |
| 2 | RVMD | Revolution Medicines Inc Ordinary Shares | 1.78% |
| 3 | ALKS | Alkermes PLC | 1.71% |
| 4 | TWST | Twist Bioscience Corp | 1.60% |
| 5 | TGTX | TG Therapeutics Inc | 1.52% |
| 6 | ARWR | Arrowhead Pharmaceuticals Inc | 1.51% |
| 7 | BEAM | Beam Therapeutics Inc | 1.42% |
| 8 | NBIX | Neurocrine Biosciences Inc | 1.37% |
| 9 | KRYS | Krystal Biotech Inc | 1.36% |
| 10 | EXEL | Exelixis Inc | 1.36% |
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
설정일: 2006-01-31